share_log

Piper Sandler Maintains Overweight on ShockWave Medical, Lowers Price Target to $280

Benzinga Real-time News ·  Jan 26, 2023 06:45

Piper Sandler analyst Adam Maeder maintains ShockWave Medical (NASDAQ:SWAV) with a Overweight and lowers the price target from $300 to $280.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment